MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Psychogenic movement disorders(PMD): Treatment"

  • MDS Virtual Congress 2020

    Managing Functional Movement Disorder in Outpatient Physical Therapy: A Case Report of Belly-Dancer Dyskinesia

    R. Hand, J. Snider, J. Utt (Richmond, VA, USA)

    Objective: Abdominal dyskinesia, often referenced as belly dancer syndrome, is a poorly understood clinical presentation involving involuntary, undulating movements of the abdomen.1 Few cases have…
  • 2019 International Congress

    A flowchart algorithm for the neurologist to discuss and attend sexual issues in Parkinson’s disease

    G. Bronner, S. Hassin-Baer, AD. Korczyn, T. Gurevich (Ramat-Gan, Israel)

    Objective: To propose guidelines for neurologists to discuss sexual issues and offer education and practical solutions. Background: Sexual dysfunction (SD) is a common nonmotor symptom…
  • 2019 International Congress

    Clinical hypnosis in functional movement disorders: a potential therapeutic strategy

    C. Buiza-Aguado, C. Ordas-Bandera, M. Guillan-Rodriguez, J. Del Val, PJ. Garcia Ruiz-Espiga, JC. Martinez-Castrillo, I. Parees-Moreno, A. Alonso-Canovas (Madrid, Spain)

    Objective: To present a patient with a functional movement disorder who was successfully treated with clinical hypnosis. Background: Functional movement disorders (FMD), specially fixed dystonia,…
  • 2019 International Congress

    The effect of intranasal oxytocin in patients with functional motor symptoms: an open label case series

    B. Demartini, D. Goeta, D. Di Benedetto, A. Casiraghi, D. Mazza, A. Priori, O. Gambini (Milano, Italy)

    Objective: Aim of this case series was to assess the effect of a single dose of intranasal oxytocin in a sample of patients with FMS…
  • 2019 International Congress

    The role of attention in functional movement disorders

    A. Huys, P. Haggard, K. Bhatia, M. Edwards (London, United Kingdom)

    Objective: Identify where the attentional focus naturally lies in functional movement disorders and evaluate which abnormal attentional foci contribute to symptom generation. The ultimate aim…
  • 2019 International Congress

    Long Term Follow Up Following Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders

    A. Kompoliti, C. Hebert, J. Behel, G. Pal, R. Kasi (Chicago, IL, USA)

    Objective: To assess the maintenance of improvement in Functional Movement Disorders (FMDs) following inpatient rehabilitation one year after discharge. Background: FMDs are chronic and challenging…
  • 2019 International Congress

    Opinions and clinical practices related to diagnosing and managing patients with functional (psychogenic) movement disorders: from 2009 to 2019

    K. Lafaver, D. Bega, M. Hallett, A. Lang, S. Lidstone, C. Maurer, F. Morgante, D. Perez, C. Stephen, J. Stone, T. Teodoro, A. Wu, A. Dwivedi, A. Espay (Louisville, KY, USA)

    Objective: (1) To examine current opinion and clinical practices related to diagnosis and management of Functional Movement Disorders (FMD); and (2) to determine if practice…
  • 2019 International Congress

    Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up

    J. Dijk, M. Tijssen, J. Koelman, Y. Dreissen, F. Lambert (Groningen, Netherlands)

    Objective: To assess the long term effect of treatment with botulinum neurotoxin (BoNT) in patients with functional jerky or tremorous movement disorders. Background: Treatment options for…
  • 2019 International Congress

    Integrated therapy for Functional Movement Disorders: results from a pilot clinic

    S. Lidstone, L. Macgillivray, C. Marras, M. Josef, L. Muc, A. Lang (Toronto, ON, Canada)

    Objective: To create a novel pilot clinic for the treatment of Functional Movement Disorders (FMD). Background: FMDs are aberrations of motor system functioning in the…
  • 2019 International Congress

    Management of Patients with Functional Movement Disorders: A Transcultural Perspective

    C. Maurer, D. Anderson, A. Asadi-Pooya, J. Baizabal, M. Damianova, C. Ganos, R. Kanaan, M. Tijssen, J. Kwasa, I. Moreno, S. Pandey, JE. Park, D. Saylor, M. Stamelou, C. Stephen, T. Teodoro, M. Tinazzi, K. Lafaver (Stony Brook, NY, USA)

    Objective: To compare the clinical management, available resources and barriers to care for patients with functional movement disorders (FMD) across 15 countries around the globe.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley